AGIO · Agios Pharmaceuticals, Inc.
$35.97
-1.00 (-2.70%)
At close · Jul 28
Market Cap
$2.14B
Shares
59.47M
Positioning
Aug 21, 2026 · 23 days to expiry · 28 contractsPut / call OI
0.48
Call-heavy positioning
Open interest
4,773
contracts outstanding
Volume
139
traded today
Max pain
$30.00
$5.97 below spot
ATM implied vol
63.4%
market's expected move
Open interest by strike
Calls
Puts
12.5
15
17.5
20
22.5
25
30
35
40
45
50
55
60
65
Chain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 0 | — | — | — | — | $0.20 | — | — | 1 | 1 | |
| 1 | 1 | — | — | $15.50 | $0.50 | -0.037 | 241.5% | 1 | 22 | |
| 0 | — | — | — | — | $0.90 | -0.044 | 203.5% | 1 | 100 | |
| 0 | 4 | — | — | $18.00 | $1.65 | -0.053 | 170.9% | 1 | 9 | |
| 0 | 2 | — | — | $13.50 | $2.50 | -0.067 | 146.3% | 1 | 5 | |
| 322 | 2 | — | — | $16.55 | $0.68 | -0.122 | 154.9% | 4 | 393 | |
| 865 | 1 | 57.2% | 0.926 | $6.98 | $0.50 | -0.126 | 74.7% | 1 | 793 | |
| 1k | 50 | 68.5% | 0.633 | $2.80 | $1.05 | -0.356 | 58.4% | 1 | 104 | |
| 201 | 3 | 52.4% | 0.269 | $0.76 | $4.83 | -0.724 | 54.4% | 1 | 51 | |
| 418 | 1 | 57.6% | 0.086 | $0.80 | $6.02 | -0.869 | 69.2% | 2 | 75 | |
| 337 | 11 | 77.7% | 0.067 | $0.15 | — | -0.862 | 102.7% | — | 0 | |
| 50 | 50 | 112.9% | 0.096 | $0.49 | — | -0.873 | 125.6% | — | 0 | |
| 0 | — | 129.7% | 0.086 | — | — | -0.873 | 149% | — | 0 | |
| 0 | — | 151.7% | 0.092 | — | — | -0.892 | 161.1% | — | 0 | |
About this data
Greeks, implied volatility, open interest and the last price come from the latest daily snapshot and are 15-minute delayed. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown. Max pain is the listed strike where the most open interest would expire worthless — a positioning reference, not a forecast.
Key facts
CIK
1439222
CUSIP
00847X104
13F (30d)
61 filings
37 filers
Visit website
Investor relations